Avascular Necrosis, Fracture, Knee, Non-inflammatory Degenerative Joint Disease, Osteoarthritis, Requires Correction of Functional Deformity
Conditions
Keywords
osteoarthritis
Brief summary
This is a prospective study to demonstrate the safety and effectiveness of CORI and to register CORI in China mainland.
Detailed description
This is a prospective, multi-center, randomized study to demonstrate the safety and effectiveness of CORI. In addition, the study will support regulatory approval by the National Medical Products Administration (NMPA) in China. The study will have two arms, the investigational group will be total knee arthroplasty (TKA) using CORI, the comparison group will be conventional approach with conventional manual instrumentation.
Interventions
unicondylar knee arthroplasty (UKA) treated with CORI
unicondylar knee arthroplasty (UKA) treated with conventional approach with conventional manual instrumentation
Sponsors
Study design
Eligibility
Inclusion criteria
1. Subject is a suitable candidate for a UKA procedure using CORI and a compatible S+N Knee implant system. 2. Subject requires a cemented UKA as a primary indication that meets any of the following conditions: 1. Non-inflammatory degenerative joint disease, including osteoarthritis 2. Avascular necrosis 3. Requires correction of functional deformity 4. Requires treatment of fractures that were unmanageable using other techniques 3. Subject is of legal age to consent and considered skeletally mature (≥ 18 years of age at the time of surgery). 4. Subject agrees to consent to and to follow the study visit schedule (as defined in the study protocol and informed consent form), by signing the Ethics Committee (EC) or Institutional Review Board (IRB) approved informed consent form. 5. Subject plans to be available through one (1) year postoperative follow-up. 6. Applicable routine radiographic assessment if possible.
Exclusion criteria
1. Subject receives a UKA on the index joint as a revision for a previously failed surgery, or need for complex implants, or any other implant than a standard UKA (e.g. stems, augments, or custom made devices). 2. Subject has been diagnosed with post-traumatic arthritis 3. Subject receives simultaneous bilateral UKA OR a unilateral UKA with contralateral TKA. 4. Subject has one or more of the following arthroplasties that are not fully healed and well-functioning, as determined by the investigator:-Contralateral primary TKA or UKA, however, the subject can only have one knee enrolled in this study. 5. Subject does not understand the language used in the Informed Consent Form. 6. Subject does not meet the indication or is contraindicated for UKA according to specific S+N knee system's Instructions For Use (IFU). 7. Subject has active infection or sepsis (treated or untreated). 8. Subject is morbidly obese with a body mass index (BMI) greater than 40. 9. Subject is pregnant or breast feeding at the time of surgery. 10. Subject, in the opinion of the Investigator, has advanced osteoarthritis or joint disease at the time of surgery and was better suited for an alternate procedure. 11. Subject currently enrolled in another orthopedic clinical trial study. 12. Subject has a condition(s) that may interfere with the UKA survival or outcome (i.e., Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease, or an active, local infection). 13. Subject in the opinion of the Investigator has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, intellectual disability, drug or alcohol abuse. 14. Subject, in the opinion of the Investigator, has a neuromuscular disorder that prohibited control of the index joint. 15. Subject is a prisoner or meets the definition of a Vulnerable Subject per ISO 14155:2020 Section 3.55.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Post-operative Leg Alignment | 6 weeks | The number of participants with knees achieving post-operative leg alignment was taken by radiographic assessment at 6 weeks. Post-operative leg alignment was achieved when the deviation from the participant specific target did not exceed ±3 degrees. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Component Alignment: Tibial Antero-Posterior (A/P) Angle | 6 weeks | Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. From the A/P radiograph, the tibial angle denotes the angle formed on the medial side of the knee from intersecting lines parallel to the tibial base plate and a line drawn parallel to the tibial canal. |
| Component Alignment: Total Antero-Posterior (A/P) Valgus Angle | 6 weeks | Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. The total valgus angle is the sum of the femoral flexion angle and the tibial angle. |
| Component Alignment: Lateral View Femoral Flexion Angle | 6 weeks | Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. The lateral view femoral flexion angle in degrees was obtained from the intersection of a line from the center of the femoral implant to the top of the femur with a line through the femoral canal. The angle is measured on the proximal side of the intersection. |
| Component Alignment: Lateral View Tibial Angle | 6 weeks | Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. The lateral view tibial angle in degrees was obtained from the intersection of a line drawn parallel to the bottom of the tibial base insert and a line through the center of the tibial base and the tibial canal. |
| Radiographic Assessment | 12 months | Radiographic assessment measured by number of participants with any radiographic finds on antero-posterior (A/P) and lateral (L) views (yes/no). Radiographic findings indicated the presence of radiolucent lines, osteolysis & implant migration. |
| 2011 Knee Society Score (KSS): Objective Knee Score | Baseline, 6 weeks, 6 months, and 12 months | The 2011 Knee Society Score consists of 4 separate sub-scales. The Objective Knee Score is seven items with a range of 0 to 100, with a higher score indicating a better outcome. |
| Component Alignment: Femoral Antero-Posterior (A/P) Angle | 6 weeks | Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. From the A/P radiograph, the femoral flexion angle in degrees was obtained using standard radiographic tools. Femoral flexion angle is defined as the angle formed between a line across the base of the femoral condyles and a line that is centered along the femoral canal. |
| 2011 Knee Society Score (KSS): Expectation Score | Baseline, 6 weeks, 6 months, and 12 months | The 2011 Knee Society Score consists of 4 separate sub-scales. The Patient Expectation Score is three items with a range of 0 to 15, with a higher score indicating a better outcome. The Expectation score indicates the patient's opinion on the extent they expect the operation to improve their knee pain, and ability to perform activities of daily living and recreational activities. |
| 2011 Knee Society Score (KSS): Functional Score | Baseline, 6 weeks, 6 months, and 12 months | The 2011 Knee Society Score consists of 4 separate sub-scales. The Functional Score is nineteen items with a range of 0 to 100, with a higher score indicating a better outcome. Functional Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities. |
| Oxford Knee Score (OKS) | Baseline, 6 weeks, 6 months, and 12 months | The Oxford Knee Score (OKS) is a Patient Reported Outcome questionnaire that was developed to assess perceived function and pain answered on a Likert scale. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome. |
| Forgotten Joint Score (FJS) | 6 weeks, 6 months, and 12 months | The Forgotten Joint Score (FJS) comprises measures for the assessment of joint-specific patient reported outcomes. Participants are asked to rate their awareness of their knee arthroplasty in 12 questions with a five point Likert response format: Never, almost never, seldom, sometimes and mostly. The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living (i.e., a higher score is a better outcome). |
| Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score | Baseline, 6 weeks, 6 months, and 12 months | The EQ-5D-5L score consists of two parts: a descriptive system and a visual analogue scale (VAS). The descriptive system (i.e., index score) is used to describe the participant's health state and consists of five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels to choose the most appropriate answer: no problems, slight problems, moderate problems, severe problems and extreme problems. The participant is asked to indicate their health state by marking the most appropriate statement in each of the five areas. The EQ-5D-5L Index Score was based on a scale of 0 to 1, with higher index values indicating better health and lower index values indicating worse health. |
| Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score | Baseline, 6 weeks, 6 months, and 12 months | The EQ-5D-5L score consists of two parts: a descriptive system and a visual analogue scale (VAS). The VAS records the participant's self-rated health on a vertical visual analogue scale. The scale ranges from 0 to 100 where 0 indicates 'The worst health you can imagine' and 100 indicates 'The best health you can imagine'. |
| 2011 Knee Society Score (KSS): Satisfaction Knee Score | Baseline, 6 weeks, 6 months, and 12 months | The 2011 Knee Society Score consists of 4 separate sub-scales. The Patient Satisfaction Score is five items with a range of 0 to 40, with a higher score indicating a better outcome. |
Countries
Australia, Hong Kong, New Zealand
Participant flow
Pre-assignment details
There were 4 participants enrolled & randomized into the study with each contributing one study knee.
Participants by arm
| Arm | Count |
|---|---|
| CORI UKA Subjects in need for unicondylar knee arthroplasty (UKA) as decided by their doctor and treated with CORI.
CORI: unicondylar knee arthroplasty (UKA) treated with CORI | 2 |
| Conventional UKA Subjects in need for unicondylar knee arthroplasty (UKA) as decided by their doctor and treated with conventional approach with conventional manual instrumentation.
Conventional: unicondylar knee arthroplasty (UKA) treated with conventional approach with conventional manual instrumentation | 2 |
| Total | 4 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Study Termination by Sponsor | 1 | 1 |
Baseline characteristics
| Characteristic | CORI UKA | Total | Conventional UKA |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 1 Participants | 3 Participants | 2 Participants |
| Age, Categorical Between 18 and 65 years | 1 Participants | 1 Participants | 0 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants | 0 Participants | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 2 Participants | 4 Participants | 2 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 1 Participants | 1 Participants | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 1 Participants | 3 Participants | 2 Participants |
| Region of Enrollment Australia | 0 participants | 1 participants | 1 participants |
| Region of Enrollment Hong Kong | 1 participants | 1 participants | 0 participants |
| Region of Enrollment New Zealand | 1 participants | 2 participants | 1 participants |
| Sex: Female, Male Female | 2 Participants | 3 Participants | 1 Participants |
| Sex: Female, Male Male | 0 Participants | 1 Participants | 1 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 2 | 0 / 2 |
| other Total, other adverse events | 2 / 2 | 1 / 2 |
| serious Total, serious adverse events | 1 / 2 | 1 / 2 |
Outcome results
Post-operative Leg Alignment
The number of participants with knees achieving post-operative leg alignment was taken by radiographic assessment at 6 weeks. Post-operative leg alignment was achieved when the deviation from the participant specific target did not exceed ±3 degrees.
Time frame: 6 weeks
Population: Overall number of participants analyzed included those enrolled in the study with data collected for the outcome and time frame specified. Leg alignment not collected for 1 participant in CORI UKA group, and target data was not collected for 1 participant in Conventional UKA group.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| CORI UKA | Post-operative Leg Alignment | 1 Participants |
| Conventional UKA | Post-operative Leg Alignment | 1 Participants |
2011 Knee Society Score (KSS): Expectation Score
The 2011 Knee Society Score consists of 4 separate sub-scales. The Patient Expectation Score is three items with a range of 0 to 15, with a higher score indicating a better outcome. The Expectation score indicates the patient's opinion on the extent they expect the operation to improve their knee pain, and ability to perform activities of daily living and recreational activities.
Time frame: Baseline, 6 weeks, 6 months, and 12 months
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CORI UKA | 2011 Knee Society Score (KSS): Expectation Score | Baseline | 13 score on a scale | Standard Deviation 1.41 |
| CORI UKA | 2011 Knee Society Score (KSS): Expectation Score | 6 weeks | 9.5 score on a scale | Standard Deviation 3.54 |
| CORI UKA | 2011 Knee Society Score (KSS): Expectation Score | 6 months | 11 score on a scale | Standard Deviation 5.66 |
| CORI UKA | 2011 Knee Society Score (KSS): Expectation Score | 12 months | 8 score on a scale | — |
| Conventional UKA | 2011 Knee Society Score (KSS): Expectation Score | 12 months | 9 score on a scale | — |
| Conventional UKA | 2011 Knee Society Score (KSS): Expectation Score | Baseline | 11 score on a scale | Standard Deviation 1.41 |
| Conventional UKA | 2011 Knee Society Score (KSS): Expectation Score | 6 months | 10 score on a scale | Standard Deviation 1.41 |
| Conventional UKA | 2011 Knee Society Score (KSS): Expectation Score | 6 weeks | 8.5 score on a scale | Standard Deviation 3.54 |
2011 Knee Society Score (KSS): Functional Score
The 2011 Knee Society Score consists of 4 separate sub-scales. The Functional Score is nineteen items with a range of 0 to 100, with a higher score indicating a better outcome. Functional Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities.
Time frame: Baseline, 6 weeks, 6 months, and 12 months
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CORI UKA | 2011 Knee Society Score (KSS): Functional Score | Baseline | 30 score on a scale | Standard Deviation 11.31 |
| CORI UKA | 2011 Knee Society Score (KSS): Functional Score | 6 weeks | 37.5 score on a scale | Standard Deviation 16.26 |
| CORI UKA | 2011 Knee Society Score (KSS): Functional Score | 6 months | 59 score on a scale | Standard Deviation 7.07 |
| CORI UKA | 2011 Knee Society Score (KSS): Functional Score | 12 months | 60 score on a scale | — |
| Conventional UKA | 2011 Knee Society Score (KSS): Functional Score | 12 months | 83 score on a scale | — |
| Conventional UKA | 2011 Knee Society Score (KSS): Functional Score | Baseline | 35.5 score on a scale | Standard Deviation 4.95 |
| Conventional UKA | 2011 Knee Society Score (KSS): Functional Score | 6 months | 72.5 score on a scale | Standard Deviation 2.12 |
| Conventional UKA | 2011 Knee Society Score (KSS): Functional Score | 6 weeks | 52 score on a scale | Standard Deviation 19.8 |
2011 Knee Society Score (KSS): Objective Knee Score
The 2011 Knee Society Score consists of 4 separate sub-scales. The Objective Knee Score is seven items with a range of 0 to 100, with a higher score indicating a better outcome.
Time frame: Baseline, 6 weeks, 6 months, and 12 months
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CORI UKA | 2011 Knee Society Score (KSS): Objective Knee Score | Baseline | 49 score on a scale | Standard Deviation 32.53 |
| CORI UKA | 2011 Knee Society Score (KSS): Objective Knee Score | 6 weeks | 62.5 score on a scale | Standard Deviation 4.95 |
| CORI UKA | 2011 Knee Society Score (KSS): Objective Knee Score | 6 months | 61.5 score on a scale | Standard Deviation 4.95 |
| CORI UKA | 2011 Knee Society Score (KSS): Objective Knee Score | 12 months | 70 score on a scale | — |
| Conventional UKA | 2011 Knee Society Score (KSS): Objective Knee Score | 12 months | 49 score on a scale | — |
| Conventional UKA | 2011 Knee Society Score (KSS): Objective Knee Score | Baseline | 33.5 score on a scale | Standard Deviation 3.54 |
| Conventional UKA | 2011 Knee Society Score (KSS): Objective Knee Score | 6 months | 50.5 score on a scale | Standard Deviation 17.68 |
| Conventional UKA | 2011 Knee Society Score (KSS): Objective Knee Score | 6 weeks | 57 score on a scale | Standard Deviation 7.07 |
2011 Knee Society Score (KSS): Satisfaction Knee Score
The 2011 Knee Society Score consists of 4 separate sub-scales. The Patient Satisfaction Score is five items with a range of 0 to 40, with a higher score indicating a better outcome.
Time frame: Baseline, 6 weeks, 6 months, and 12 months
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CORI UKA | 2011 Knee Society Score (KSS): Satisfaction Knee Score | Baseline | 19 score on a scale | Standard Deviation 1.41 |
| CORI UKA | 2011 Knee Society Score (KSS): Satisfaction Knee Score | 6 weeks | 24 score on a scale | Standard Deviation 0 |
| CORI UKA | 2011 Knee Society Score (KSS): Satisfaction Knee Score | 6 months | 28 score on a scale | Standard Deviation 2.83 |
| CORI UKA | 2011 Knee Society Score (KSS): Satisfaction Knee Score | 12 months | 34 score on a scale | — |
| Conventional UKA | 2011 Knee Society Score (KSS): Satisfaction Knee Score | 12 months | 30 score on a scale | — |
| Conventional UKA | 2011 Knee Society Score (KSS): Satisfaction Knee Score | Baseline | 10 score on a scale | Standard Deviation 2.83 |
| Conventional UKA | 2011 Knee Society Score (KSS): Satisfaction Knee Score | 6 months | 26 score on a scale | Standard Deviation 2.83 |
| Conventional UKA | 2011 Knee Society Score (KSS): Satisfaction Knee Score | 6 weeks | 23 score on a scale | Standard Deviation 4.24 |
Component Alignment: Femoral Antero-Posterior (A/P) Angle
Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. From the A/P radiograph, the femoral flexion angle in degrees was obtained using standard radiographic tools. Femoral flexion angle is defined as the angle formed between a line across the base of the femoral condyles and a line that is centered along the femoral canal.
Time frame: 6 weeks
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CORI UKA | Component Alignment: Femoral Antero-Posterior (A/P) Angle | 97 degrees | — |
| Conventional UKA | Component Alignment: Femoral Antero-Posterior (A/P) Angle | 95 degrees | Standard Deviation 1.41 |
Component Alignment: Lateral View Femoral Flexion Angle
Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. The lateral view femoral flexion angle in degrees was obtained from the intersection of a line from the center of the femoral implant to the top of the femur with a line through the femoral canal. The angle is measured on the proximal side of the intersection.
Time frame: 6 weeks
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CORI UKA | Component Alignment: Lateral View Femoral Flexion Angle | 0 degrees | — |
| Conventional UKA | Component Alignment: Lateral View Femoral Flexion Angle | 5 degrees | Standard Deviation 0 |
Component Alignment: Lateral View Tibial Angle
Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. The lateral view tibial angle in degrees was obtained from the intersection of a line drawn parallel to the bottom of the tibial base insert and a line through the center of the tibial base and the tibial canal.
Time frame: 6 weeks
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CORI UKA | Component Alignment: Lateral View Tibial Angle | 86 degrees | — |
| Conventional UKA | Component Alignment: Lateral View Tibial Angle | 85.5 degrees | Standard Deviation 0.71 |
Component Alignment: Tibial Antero-Posterior (A/P) Angle
Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. From the A/P radiograph, the tibial angle denotes the angle formed on the medial side of the knee from intersecting lines parallel to the tibial base plate and a line drawn parallel to the tibial canal.
Time frame: 6 weeks
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CORI UKA | Component Alignment: Tibial Antero-Posterior (A/P) Angle | 84 degrees | — |
| Conventional UKA | Component Alignment: Tibial Antero-Posterior (A/P) Angle | 89 degrees | Standard Deviation 5.66 |
Component Alignment: Total Antero-Posterior (A/P) Valgus Angle
Component alignment assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery. The total valgus angle is the sum of the femoral flexion angle and the tibial angle.
Time frame: 6 weeks
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CORI UKA | Component Alignment: Total Antero-Posterior (A/P) Valgus Angle | 181 degrees | — |
| Conventional UKA | Component Alignment: Total Antero-Posterior (A/P) Valgus Angle | 184 degrees | Standard Deviation 7.07 |
Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score
The EQ-5D-5L score consists of two parts: a descriptive system and a visual analogue scale (VAS). The descriptive system (i.e., index score) is used to describe the participant's health state and consists of five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels to choose the most appropriate answer: no problems, slight problems, moderate problems, severe problems and extreme problems. The participant is asked to indicate their health state by marking the most appropriate statement in each of the five areas. The EQ-5D-5L Index Score was based on a scale of 0 to 1, with higher index values indicating better health and lower index values indicating worse health.
Time frame: Baseline, 6 weeks, 6 months, and 12 months
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CORI UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score | Baseline | 0.71 score on a scale | Standard Deviation 0.03 |
| CORI UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score | 6 weeks | 0.69 score on a scale | Standard Deviation 0.13 |
| CORI UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score | 6 months | 0.81 score on a scale | Standard Deviation 0.02 |
| CORI UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score | 12 months | 0.80 score on a scale | — |
| Conventional UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score | 12 months | 0.77 score on a scale | — |
| Conventional UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score | Baseline | 0.58 score on a scale | Standard Deviation 0.01 |
| Conventional UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score | 6 months | 0.83 score on a scale | Standard Deviation 0.04 |
| Conventional UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Index Score | 6 weeks | 0.79 score on a scale | Standard Deviation 0.01 |
Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score
The EQ-5D-5L score consists of two parts: a descriptive system and a visual analogue scale (VAS). The VAS records the participant's self-rated health on a vertical visual analogue scale. The scale ranges from 0 to 100 where 0 indicates 'The worst health you can imagine' and 100 indicates 'The best health you can imagine'.
Time frame: Baseline, 6 weeks, 6 months, and 12 months
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CORI UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score | Baseline | 67.5 score on a scale | Standard Deviation 17.68 |
| CORI UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score | 6 weeks | 72.5 score on a scale | Standard Deviation 10.61 |
| CORI UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score | 6 months | 85 score on a scale | Standard Deviation 7.07 |
| CORI UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score | 12 months | 80 score on a scale | — |
| Conventional UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score | 12 months | 75 score on a scale | — |
| Conventional UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score | Baseline | 55 score on a scale | Standard Deviation 7.07 |
| Conventional UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score | 6 months | 72.5 score on a scale | Standard Deviation 17.68 |
| Conventional UKA | Five-level EuroQol Five-dimensional (EQ-5D-5L): Visal Analogue Scale (VAS) Score | 6 weeks | 72.5 score on a scale | Standard Deviation 10.61 |
Forgotten Joint Score (FJS)
The Forgotten Joint Score (FJS) comprises measures for the assessment of joint-specific patient reported outcomes. Participants are asked to rate their awareness of their knee arthroplasty in 12 questions with a five point Likert response format: Never, almost never, seldom, sometimes and mostly. The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living (i.e., a higher score is a better outcome).
Time frame: 6 weeks, 6 months, and 12 months
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CORI UKA | Forgotten Joint Score (FJS) | 6 weeks | 13.54 score on a scale | Standard Deviation 10.31 |
| CORI UKA | Forgotten Joint Score (FJS) | 6 months | 52.08 score on a scale | Standard Deviation 8.84 |
| CORI UKA | Forgotten Joint Score (FJS) | 12 months | 18.75 score on a scale | — |
| Conventional UKA | Forgotten Joint Score (FJS) | 6 weeks | 29.17 score on a scale | Standard Deviation 11.79 |
| Conventional UKA | Forgotten Joint Score (FJS) | 6 months | 67.71 score on a scale | Standard Deviation 1.47 |
| Conventional UKA | Forgotten Joint Score (FJS) | 12 months | 87.5 score on a scale | — |
Oxford Knee Score (OKS)
The Oxford Knee Score (OKS) is a Patient Reported Outcome questionnaire that was developed to assess perceived function and pain answered on a Likert scale. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.
Time frame: Baseline, 6 weeks, 6 months, and 12 months
Population: Overall number of participants analyzed included those enrolled with data collected for the outcome and time frame specified.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CORI UKA | Oxford Knee Score (OKS) | Baseline | 22.5 score on a scale | Standard Deviation 0.71 |
| CORI UKA | Oxford Knee Score (OKS) | 6 weeks | 16 score on a scale | Standard Deviation 2.83 |
| CORI UKA | Oxford Knee Score (OKS) | 12 months | 38 score on a scale | — |
| CORI UKA | Oxford Knee Score (OKS) | 6 months | 35.5 score on a scale | Standard Deviation 0.71 |
| Conventional UKA | Oxford Knee Score (OKS) | 6 months | 35 score on a scale | Standard Deviation 8.49 |
| Conventional UKA | Oxford Knee Score (OKS) | Baseline | 18.5 score on a scale | Standard Deviation 3.54 |
| Conventional UKA | Oxford Knee Score (OKS) | 12 months | 41 score on a scale | — |
| Conventional UKA | Oxford Knee Score (OKS) | 6 weeks | 29.5 score on a scale | Standard Deviation 2.12 |
Radiographic Assessment
Radiographic assessment measured by number of participants with any radiographic finds on antero-posterior (A/P) and lateral (L) views (yes/no). Radiographic findings indicated the presence of radiolucent lines, osteolysis & implant migration.
Time frame: 12 months
Population: Overall number of participants analyzed indicated those enrolled in the study with data collected for the outcome and time frame specified. Data was not collected for 2 participants due to the early termination of the study.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| CORI UKA | Radiographic Assessment | No | 1 Participants |
| CORI UKA | Radiographic Assessment | Yes | 0 Participants |
| Conventional UKA | Radiographic Assessment | No | 1 Participants |
| Conventional UKA | Radiographic Assessment | Yes | 0 Participants |